Human dendritic cells induce tumor-specific apoptosis by soluble factors

International Journal of Cancer

Volumn 102, Issue 1, 2002, Pages 20-28

  Joo, Hong Gu ^a   Fleming, Timothy P ^a   Tanaka, Yoshiyuki ^a   Dunn, Toby J ^a   Linehan, David C ^a   Goedegebuure, Peter S ^a   Eberlein, Timothy J ^a,b  

^a USA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cellular activation; Dendritic cells; Tumor immunity

Indexed keywords

CD40 LIGAND; FAS LIGAND; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST TUMOR; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL FRACTIONATION; CELL MATURATION; CELL PROLIFERATION; CELL STRUCTURE; COCULTURE; CONTROLLED STUDY; DENDRITIC CELL; FIBROBLAST; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR GROWTH;

ANNEXIN A5; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD40; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BREAST NEOPLASMS; CD40 LIGAND; CELL CYCLE; COCULTURE TECHNIQUES; DENDRITIC CELLS; FIBROBLASTS; HUMANS; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MONOCYTES; NECROSIS; RNA, MESSENGER; T-LYMPHOCYTES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036837234     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10656     Document Type: Article

References (19)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 2000;392:245-52.
2. Fernandez NC, Lozier A, Flament C, Ricciardi- Castagnoli P, Bellet D, Suter M, Perricaudet M, Tursz T, Maraskovsky E, Zitvogel L. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 1999;5:405-11.
3. Labeur MS, Roters B, Pers B, Mehling A, Luger TA, Schwarz T, Grabbe S. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J Immunol 1999;162:168-75.
4. Hartmann G, Weiner GJ, Krieg AM. CpG DNA: a potent signal for growth, activation and maturation of human dendritic cells. Proc Natl Acad Sci USA 1999;96:9305-10.
5. Larsson M, Fonteneau JF, Bhardwaj N. Dendritic cells resurrect antigens from dead cells. Trends Immunol 2001;22:141-8.
6. Hoffmann TK, Meidenbauer N, Dworacki G, Kanaya H, Whiteside TL. Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor.cells. Cancer Res 2000;60:3542-9.
7. Nouri-Shirazi M, Banchereau J, Bell D, Burkeholder S, Kraus ET, Davoust J, Palucka KA. Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses. J Immunol 2000; 165:3797-803.
8. Yang S, Darrow TL, Vervaert CE, Seigler HF. Immunotherapeutic potential of tumor antigen-pulsed and unpulsed dendritic cells generated from murine bone marrow. Cell Immunol 1997;179:84-95.
9. Candido KA, Shimizu K, McLaughlin JC, Kunkel R, Fuller JA, Redman BG, Thomas EK, Nickoloff BJ, Mulé JJ. Local administration of dendritic cells inhibits established breast tumor growth: implications for apoptosis-inducing agents. Cancer Res 2001;61:228-36.
10. Lu L, Qian S, Hershberger PA, Rudert WA, Lynch DH, Thomson AW. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J Immunol 1997;158:5676-84.
11. Lu L, Bonham A, Chambers FG, Watkins SC, Hoffman RA, Simmons RL, Thomson AW. Induction of nitric oxide synthase in mouse dendritic cells by IFN-γ, endotoxin and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis. J Immunol 1996;157:3577-86.
12. Vidalain PO, Azocar O, Yagita H, Rabourdin-Combe C, Servet-Delprat C. Cytotoxic activity of human dendritic cells is differentially regulated by double-stranded RNA and CD40 ligand. J Immunol 2001;167:3765-72.
13. Vanderheyde N, Aksoy E, Amraoui Z, Vandenabeele P, Goldman M, Willems F. Tumoricidal activity of monocyte-derived dendritic cells: Evidence for a caspase-8-dependent, Fas-associated death domain-independent mechanism. J Immunol 2001;167:3565-9.
14. Hirano A, Longo DL, Taub DD, Ferris DK, Young LS, Eliopoulos AG, Agathanggelou A, Cullen N, Macartney J, Fanslow WC, Murphy WJ. Inhibition of human breast carcinoma growth by a soluble recombinant human CD40 ligand. Blood 1999;93:2999-3007.
15. Josien R, Heslan M, Soulillou JP, Cuturi MC. Rat spleen dendritic cells express natural killer cell receptor protein 1 (NKR- P1) and have cytotoxic activity to select targets via a Ca"-dependent mechanism. J Exp Med 1997;186:467-72.
16. Fanger NA, Maliszewski CR, Schooley K, Griffith TS. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis- inducing ligand (TRAIL). J Exp Med 1999;190:1155-64.
17. Chapoval Al, Tamada K, Chen L. in vitro growth inhibition of a broad spectrum of tumor cell lines by activated human dendritic cells. Blood 2000;95:2346-51.
18. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin- 12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996:184:747-52.
19. Lapointe R, Toso JF, Butts C, Young HA, Hwu P. Human dendritic cells require multiple activation signals for the efficient generation of tumor antigen-specific T lymphocytes. Eur J Immunol 2000;30:3291-8.